These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29896666)

  • 1. Vaccine Development for Varicella-Zoster Virus.
    Sadaoka T; Mori Y
    Adv Exp Med Biol; 2018; 1045():123-142. PubMed ID: 29896666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model.
    Zerboni L; Hinchliffe S; Sommer MH; Ito H; Besser J; Stamatis S; Cheng J; Distefano D; Kraiouchkine N; Shaw A; Arvin AM
    Virology; 2005 Feb; 332(1):337-46. PubMed ID: 15661165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Recombinant Herpes Zoster Vaccine for Primary Immunization of Varicella-seronegative Transplant Recipients.
    L'Huillier AG; Hirzel C; Ferreira VH; Ierullo M; Ku T; Selzner N; Schiff J; Juvet S; Miao C; Schmid DS; Humar A; Kumar D
    Transplantation; 2021 Oct; 105(10):2316-2323. PubMed ID: 33528118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Genetic Insights Into Varicella Zoster Virus (VZV), the vOka Vaccine Strain, and the Pathogenesis of Latency and Reactivation.
    Breuer J
    J Infect Dis; 2018 Sep; 218(suppl_2):S75-S80. PubMed ID: 30247591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella-zoster virus: molecular controls of cell fusion-dependent pathogenesis.
    Oliver SL; Zhou M; Arvin AM
    Biochem Soc Trans; 2020 Dec; 48(6):2415-2435. PubMed ID: 33259590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Live Attenuated Zoster Vaccine Boosts Varicella Zoster Virus (VZV)-Specific Humoral Responses Systemically and at the Cervicovaginal Mucosa of Kenyan VZV-Seropositive Women.
    Perciani CT; Sekhon M; Hundal S; Farah B; Ostrowski MA; Anzala AO; McKinnon LR; Jaoko W; MacDonald KS;
    J Infect Dis; 2018 Sep; 218(8):1210-1218. PubMed ID: 29800309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation.
    Perciani CT; Farah B; Kaul R; Ostrowski MA; Mahmud SM; Anzala O; Jaoko W; ; MacDonald KS
    J Clin Invest; 2019 Feb; 129(2):875-886. PubMed ID: 30511963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varicella-zoster virus vaccine: molecular genetics.
    Schmid DS
    Curr Top Microbiol Immunol; 2010; 342():323-40. PubMed ID: 20225010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The attenuated genotype of varicella-zoster virus includes an ORF0 transitional stop codon mutation.
    Peters GA; Tyler SD; Carpenter JE; Jackson W; Mori Y; Arvin AM; Grose C
    J Virol; 2012 Oct; 86(19):10695-703. PubMed ID: 22837206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Varicella-zoster virus (VZV)].
    Kanai K; Yamada S; Inoue N
    Uirusu; 2010 Dec; 60(2):197-207. PubMed ID: 21488333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Variant Allele in Varicella-Zoster Virus Glycoprotein B Selected during Production of the Varicella Vaccine Contributes to Its Attenuation.
    Sadaoka T; Depledge DP; Rajbhandari L; Breuer J; Venkatesan A; Cohen JI
    mBio; 2022 Aug; 13(4):e0186422. PubMed ID: 35916400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus.
    Laing KJ; Russell RM; Dong L; Schmid DS; Stern M; Magaret A; Haas JG; Johnston C; Wald A; Koelle DM
    J Infect Dis; 2015 Oct; 212(7):1022-31. PubMed ID: 25784732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel polyvalent live vaccine against varicella-zoster and mumps virus infections.
    Matsuura M; Somboonthum P; Murakami K; Ota M; Shoji M; Kawabata K; Mizuguchi H; Gomi Y; Yamanishi K; Mori Y
    Microbiol Immunol; 2013 Oct; 57(10):704-14. PubMed ID: 23905963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Whole-Genome Sequence of an Oka Varicella Vaccine from China with Other Oka Vaccine Strains Reveals Sites Putatively Critical for Vaccine Efficacy.
    Wu Q; Rivailler P; Xu S; Xu W
    J Virol; 2019 May; 93(9):. PubMed ID: 30728261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varicella-zoster virus clades circulating in Spain over two decades.
    González I; Molina-Ortega A; Pérez-Romero P; Echevarría JE; He L; Tarragó D
    J Clin Virol; 2019 Jan; 110():17-21. PubMed ID: 30517902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of varicella-zoster virus-encoded ORF0 gene--comparison of parental and vaccine strains.
    Koshizuka T; Ota M; Yamanishi K; Mori Y
    Virology; 2010 Sep; 405(2):280-8. PubMed ID: 20598727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunobiology of Varicella-Zoster Virus Infection.
    Laing KJ; Ouwendijk WJD; Koelle DM; Verjans GMGM
    J Infect Dis; 2018 Sep; 218(suppl_2):S68-S74. PubMed ID: 30247598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Varicella-zoster virus-specific cell-mediated immunity by interferon-γ Enzyme-Linked Immunosorbent Assay in adults ≥50 years of age administered a herpes zoster vaccine.
    Yang P; Chen Z; Zhang J; Li W; Zhu C; Qiu P; Quan Y; Cui X; Yuan L; Jiang C
    J Med Virol; 2019 May; 91(5):829-835. PubMed ID: 30613990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives on vaccines against varicella-zoster virus infections.
    Gershon AA; Gershon MD
    Curr Top Microbiol Immunol; 2010; 342():359-72. PubMed ID: 20232192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational Design of a Skin- and Neuro-Attenuated Live Varicella Vaccine: A Review and Future Perspectives.
    Wang W; Pan D; Cheng T; Zhu H
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.